These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 27322535)

  • 21. Is it safe to stop anticoagulants after successful surgery for atrial fibrillation?
    Michael Gray R; Nagendran M; Maruthappu M
    Interact Cardiovasc Thorac Surg; 2011 Dec; 13(6):642-8. PubMed ID: 21885540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bleeding complications associated with warfarin treatment in ischemic stroke patients with atrial fibrillation: a population-based cohort study.
    Seet RC; Rabinstein AA; Christianson TJ; Petty GW; Brown RD
    J Stroke Cerebrovasc Dis; 2013 May; 22(4):561-9. PubMed ID: 23499334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Warfarin persistence among atrial fibrillation patients - why is treatment ended?
    Björck F; Ek A; Johansson L; Själander A
    Cardiovasc Ther; 2016 Dec; 34(6):468-474. PubMed ID: 27565120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ischemic Stroke in Nonvalvular Atrial Fibrillation at Warfarin Initiation: Assessment via a Large Insurance Database.
    Tepper PG; Liu X; Hamilton M; Mardekian J; Petkun W; Tan W; Singer DE
    Stroke; 2017 Jun; 48(6):1487-1494. PubMed ID: 28446621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significant underuse of warfarin in patients with nonvalvular atrial fibrillation: results from the China national stroke registry.
    Wang C; Yang Z; Wang C; Wang Y; Zhao X; Liu L; Wang DZ; Li H; Wang Y
    J Stroke Cerebrovasc Dis; 2014; 23(5):1157-63. PubMed ID: 24291013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liver Cirrhosis in Patients With Atrial Fibrillation: Would Oral Anticoagulation Have a Net Clinical Benefit for Stroke Prevention?
    Kuo L; Chao TF; Liu CJ; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Liao JN; Chung FP; Chen TJ; Lip GYH; Chen SA
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28645935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prior Anticoagulation and Short- or Long-Term Clinical Outcomes in Ischemic Stroke or Transient Ischemic Attack Patients With Nonvalvular Atrial Fibrillation.
    Tokunaga K; Koga M; Itabashi R; Yamagami H; Todo K; Yoshimura S; Kimura K; Sato S; Terasaki T; Inoue M; Shiokawa Y; Takagi M; Kamiyama K; Tanaka K; Takizawa S; Shiozawa M; Okuda S; Okada Y; Kameda T; Nagakane Y; Hasegawa Y; Shibuya S; Ito Y; Matsuoka H; Takamatsu K; Nishiyama K; Kario K; Yagita Y; Fujita K; Ando D; Kumamoto M; Arihiro S; Toyoda K;
    J Am Heart Assoc; 2019 Feb; 8(3):e010593. PubMed ID: 30691339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of suboptimal anticoagulation treatment with antiplatelet therapy and warfarin on clinical outcomes in patients with nonvalvular atrial fibrillation: A population-wide cohort study.
    Chan EW; Lau WC; Siu CW; Lip GY; Leung WK; Anand S; Man KK; Wong IC
    Heart Rhythm; 2016 Aug; 13(8):1581-8. PubMed ID: 27033342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and efficacy of non-vitamin K oral anticoagulant treatment compared with warfarin in patients with non-valvular atrial fibrillation who develop acute ischemic stroke or transient ischemic attack: a multicenter prospective cohort study (daVinci study).
    Saji N; Kimura K; Tateishi Y; Fujimoto S; Kaneko N; Urabe T; Tsujino A; Iguchi Y;
    J Thromb Thrombolysis; 2016 Nov; 42(4):453-62. PubMed ID: 27207691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between warfarin use and incidence of ischemic stroke in Japanese hemodialysis patients with chronic sustained atrial fibrillation: a prospective cohort study.
    Wakasugi M; Kazama JJ; Tokumoto A; Suzuki K; Kageyama S; Ohya K; Miura Y; Kawachi M; Takata T; Nagai M; Ohya M; Kutsuwada K; Okajima H; Ei I; Takahashi S; Narita I
    Clin Exp Nephrol; 2014 Aug; 18(4):662-9. PubMed ID: 24113782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of ischemic stroke after atrial fibrillation diagnosis: A national sample cohort.
    Son MK; Lim NK; Kim HW; Park HY
    PLoS One; 2017; 12(6):e0179687. PubMed ID: 28636620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.
    Arihiro S; Todo K; Koga M; Furui E; Kinoshita N; Kimura K; Yamagami H; Terasaki T; Yoshimura S; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Nagakane Y; Kameda T; Hasegawa Y; Shibuya S; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Matsuki T; Homma K; Takasugi J; Tokunaga K; Sato S; Kario K; Kitazono T; Toyoda K;
    Int J Stroke; 2016 Jul; 11(5):565-74. PubMed ID: 26927811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current trial-associated outcomes with warfarin in prevention of stroke in patients with nonvalvular atrial fibrillation: a meta-analysis.
    Agarwal S; Hachamovitch R; Menon V
    Arch Intern Med; 2012 Apr; 172(8):623-31; discussion 631-3. PubMed ID: 22450212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carotid atherosclerosis and risk for ischemic stroke in patients with atrial fibrillation on oral anticoagulant treatment.
    Becattini C; Dentali F; Camporese G; Sembolini A; Rancan E; Tonello C; Manina G; Padayattil S; Agnelli G
    Atherosclerosis; 2018 Apr; 271():177-181. PubMed ID: 29524860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of Nonvitamin K Antagonist Oral Anticoagulants and Warfarin for Preventing Further Cerebral Microbleeds in Acute Ischemic Stroke Patients with Nonvalvular Atrial Fibrillation and At Least One Microbleed: CMB-NOW Multisite Pilot Trial.
    Yokoyama M; Mizuma A; Terao T; Tanaka F; Nishiyama K; Hasegawa Y; Nagata E; Nogawa S; Kobayashi H; Yanagimachi N; Okazaki T; Kitagawa K; Takizawa S;
    J Stroke Cerebrovasc Dis; 2019 Jul; 28(7):1918-1925. PubMed ID: 31005561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potentially preventable strokes in high-risk patients with atrial fibrillation who are not adequately anticoagulated.
    Gladstone DJ; Bui E; Fang J; Laupacis A; Lindsay MP; Tu JV; Silver FL; Kapral MK
    Stroke; 2009 Jan; 40(1):235-40. PubMed ID: 18757287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rates of ischemic stroke during warfarin treatment for atrial fibrillation.
    Tung JM; Mamdani MM; Juurlink DN; Paterson JM; Kapral MK; Gomes T
    Stroke; 2015 Apr; 46(4):1120-2. PubMed ID: 25700291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Major bleeding in patients with atrial fibrillation receiving apixaban or warfarin: The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation): Predictors, Characteristics, and Clinical Outcomes.
    Hylek EM; Held C; Alexander JH; Lopes RD; De Caterina R; Wojdyla DM; Huber K; Jansky P; Steg PG; Hanna M; Thomas L; Wallentin L; Granger CB
    J Am Coll Cardiol; 2014 May; 63(20):2141-2147. PubMed ID: 24657685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicting Major Bleeding in Ischemic Stroke Patients With Atrial Fibrillation.
    Hilkens NA; Algra A; Greving JP
    Stroke; 2017 Nov; 48(11):3142-3144. PubMed ID: 28931618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes After Warfarin Initiation in a Cohort of Hemodialysis Patients With Newly Diagnosed Atrial Fibrillation.
    Shen JI; Montez-Rath ME; Lenihan CR; Turakhia MP; Chang TI; Winkelmayer WC
    Am J Kidney Dis; 2015 Oct; 66(4):677-88. PubMed ID: 26162653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.